The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

被引:102
作者
Hay, CRM [1 ]
Baglin, TP [1 ]
Collins, PW [1 ]
Hill, FGH [1 ]
Keeling, DM [1 ]
机构
[1] Univ Manchester, Manchester Royal Infirm, Dept Haematol, Manchester Haemophilia Comprehens Care Ctr, Manchester M13 9WL, Lancs, England
关键词
diagnosis; management; factor VIII/IX inhibitors;
D O I
10.1046/j.1365-2141.2000.02327.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:78 / 90
页数:13
相关论文
共 97 条
[1]   FREQUENCY OF INHIBITOR DEVELOPMENT IN HEMOPHILIACS TREATED WITH LOW-PURITY FACTOR-VIII [J].
ADDIEGO, J ;
KASPER, C ;
ABILDGAARD, C ;
HILGARTNER, M ;
LUSHER, J ;
GLADER, B ;
ALEDORT, L .
LANCET, 1993, 342 (8869) :462-464
[2]   VONWILLEBRAND-FACTOR CONTAMINATING PORCINE FACTOR-VIII CONCENTRATE (HYATE-C) CAUSES PLATELET-AGGREGATION [J].
ALTIERI, DC ;
CAPITANIO, AM ;
MANNUCCI, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 63 (04) :703-711
[3]  
[Anonymous], AC PAIN MAN OP MED P
[4]  
Bech RM, 1996, HAEMOSTASIS, V26, P135
[5]   Immune tolerance and the immune modulation protocol [J].
Berntorp, E ;
Nilsson, IM .
VOX SANGUINIS, 1996, 70 :36-41
[6]  
BONA RD, 1993, SEMIN HEMATOL, V30, P32
[7]  
BRACKMANN H, 1986, PROG CLIN BIOL RES, V150, P181
[8]   THE USE OF PORCINE FACTOR-VIII CONCENTRATE (HYATE-C) IN THE TREATMENT OF PATIENTS WITH INHIBITOR ANTIBODIES TO FACTOR-VIII - A MULTICENTER US EXPERIENCE [J].
BRETTLER, DB ;
FORSBERG, AD ;
LEVINE, PH ;
ALEDORT, LM ;
HILGARTNER, MW ;
KASPER, CK ;
LUSHER, JM ;
MCMILLAN, C ;
ROBERTS, H .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) :1381-1385
[9]  
Chang H, 1998, AM J HEMATOL, V57, P200, DOI 10.1002/(SICI)1096-8652(199803)57:3<200::AID-AJH3>3.0.CO
[10]  
2-Z